Clinical Trials Sponsored by Renew Life Formulas Inc
Total 2 results
-
Renew Life Formulas IncSprim Advanced Life SciencesUnknown
-
University of California, DavisRenew Life Formulas IncCompleted
Sponsors and Collaborators
- Societa Italiana di Endoscopia Digestiva
- San MediTech(Huzhou)Co.,Ltd.
- Alberta Children's Hospital, Calgary, Canada
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- Donders Institute for Brain, Cognition and Behavior
- Rui-hua Xu, MD, PhD
- University Medical Center Goettingen
- CRMBM-CEMEREM
- Norsk Proteinintolerance, Norway
- AMTC & Associates
- Cardresearch
- Victor Montori
- Diego Hernan Giunta, MD
- Celtaxsys Aus Pty Limited
- Fondren Orthopedic Group L.L.P.
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- ProteoSys AG
- The Fifth Affiliated Hospital of Zunyi Medical College
- Elim Pediatric Pharmaceuticals Inc.
- Caritas Freetown
- View Full List
Medical Conditions
- Spermatogenesis Arrest
- Non-compressible Torso Hemorrhage
- Disturbance of Activity and Attention
- Plasmodium Falciparum Malaria (Drug Resistant)
- Postcomatose Unawareness State
- Lymphedema of Arm
- Atrial Fibrillation, Postoperative
- Fever, Sweats, and Hot Flashes
- Normal Diameter of Optic Nerve
- Prostate Cancer Recurrent
- Stereotactic Radioablation for Ventricular Tachycardia
- Gynecologic Cancer
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Malignant Ascites Due to Epithelial Carcinoma
- Non-dystrophic Myotonias
- Fibromyalgia Syndrome, Primary
- Tube Disorders Eustachian
- Tularaemia
- Auditory Hallucination, Verbal
- Orbital Tumor
- View Full List
Drug Interventions
- SERETIDE Diskus
- Topotecan
- Polyethylene glycol 3350
- Insulin
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- PF-00868554
- Flibanserin 100 mg dose every evening
- Bortezomib/dexamethasone
- Mupirocin Calcium
- Lamivudine
- Indoximod
- Cetrorelix 78 mg + 78 mg
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Oxycodone, fentanyl
- Ruxolitinib
- Cytarabine ARA-C
- Epimedium Prenylflavonoids Extract
- Atezolizumab
- Enzalutamide, Abiraterone
- Methotrexate
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Brazil
- Contract Research Organizations in Cameroon
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Israel
- Contract Research Organizations in Moldova
- Contract Research Organizations in Myanmar
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Oman
- Contract Research Organizations in Portugal
- Contract Research Organizations in Slovakia
- Contract Research Organizations in Thailand
- Contract Research Organizations in Zimbabwe
- CRO list by country